Literature DB >> 16101491

Target practice: aiming at satellite repeats with DNA minor groove binders.

Guillaume Susbielle1, Roxane Blattes, Vanessa Brevet, Caroline Monod, Emmanuel Käs.   

Abstract

Much progress has been made in recent years in developing small molecules that target the minor groove of DNA. Striking advances have led to the design of synthetic molecules that recognize specific DNA sequences with affinities comparable to those of eukaryotic transcription factors. This makes it feasible to modulate or inhibit DNA/protein interactions in vivo, a major step towards the development of general strategies of anti-gene therapy. Examples from anti-parasitic drugs also suggest that synthetic molecules can affect a variety of cellular functions crucial to cell viability by more generally targeting vast portions of genomes based on their biased base composition. This provides a rationale for developing approaches based on selective interactions with broad genomic targets such as satellite repeats that are associated with structural or architectural components of chromatin essential for cellular proliferation. Using examples drawn from the Drosophila melanogaster model system, we review here the use of synthetic polyamides or diamidines that bind the DNA minor groove and can be used as highly selective agents capable of interfering with specific protein/DNA interactions that occur in A+T-rich repeated sequences that constitute a significant portion of eukaryotic genomes. The satellite localization of cellular proteins that bind the minor groove of DNA via domains such as the AT hook motif is highly sensitive to these molecules. A major consequence of the competition between these proteins and their synthetic mimics is an alteration of the nuclear localization and function of proteins such as topoisomerase II, a major target of anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101491     DOI: 10.2174/1568011054222355

Source DB:  PubMed          Journal:  Curr Med Chem Anticancer Agents        ISSN: 1568-0118


  9 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity.

Authors:  J F M Leal; M Martínez-Díez; V García-Hernández; V Moneo; A Domingo; J A Bueren-Calabuig; A Negri; F Gago; M J Guillén-Navarro; P Avilés; C Cuevas; L F García-Fernández; C M Galmarini
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Displacement of D1, HP1 and topoisomerase II from satellite heterochromatin by a specific polyamide.

Authors:  Roxane Blattes; Caroline Monod; Guillaume Susbielle; Olivier Cuvier; Jian-hong Wu; Tao-shih Hsieh; Ulrich K Laemmli; Emmanuel Käs
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

4.  Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.

Authors:  Rebecca M Baron; Silvia Lopez-Guzman; Dario F Riascos; Alvaro A Macias; Matthew D Layne; Guiying Cheng; Cailin Harris; Su Wol Chung; Raymond Reeves; Ulrich H von Andrian; Mark A Perrella
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

5.  Design of DNA minor groove binding diamidines that recognize GC base pair sequences: a dimeric-hinge interaction motif.

Authors:  Manoj Munde; Mohamed A Ismail; Reem Arafa; Paul Peixoto; Catharine J Collar; Yang Liu; Laixing Hu; Marie-Hélène David-Cordonnier; Amélie Lansiaux; Christian Bailly; David W Boykin; W David Wilson
Journal:  J Am Chem Soc       Date:  2007-10-13       Impact factor: 15.419

6.  An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.

Authors:  Sonia Chelouah; Caroline Monod-Wissler; Christian Bailly; Jean-Marc Barret; Nicolas Guilbaud; Stéphane Vispé; Emmanuel Käs
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

7.  Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: insight from molecular dynamics simulations.

Authors:  Juan A Bueren-Calabuig; Christophe Giraudon; Carlos M Galmarini; Jean Marc Egly; Federico Gago
Journal:  Nucleic Acids Res       Date:  2011-07-03       Impact factor: 16.971

Review 8.  Deep structural insights into RNA-binding disordered protein regions.

Authors:  András Zeke; Éva Schád; Tamás Horváth; Rawan Abukhairan; Beáta Szabó; Agnes Tantos
Journal:  Wiley Interdiscip Rev RNA       Date:  2022-01-30       Impact factor: 9.349

Review 9.  Chromatin as a target for the DNA-binding anticancer drugs.

Authors:  Parijat Majumder; Suman K Pradhan; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  Subcell Biochem       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.